Skip to main content

22 May 2024 - Commercialising Research - Oral evidence

Committee Science, Innovation and Technology Committee
Inquiry Commercialising Research

Wednesday 22 May 2024

Start times: 9:20am (private) 9:30am (public)


Add to calendar

On Wednesday 22 May the SITC will begin to explore a theme that has been emerging across its inquiries from UK astronomy to quantum technologies and even bacteria-eating viruses:   

How can the UK Government and its agencies best support the transition from the UK’s world leading scientific research base into commercial and industrial applications with potential benefits for health, the economy and wider society?

Meeting details

At 9:30am: Oral evidence
Work Commercialising Research (Non-inquiry session)
CEO at Purespring Therapeutics
CEO at Micro-Fresh
At 10:15am: Oral evidence
Work Commercialising Research (Non-inquiry session)
Executive Director at Fraunhofer UK
Director of Policy at High Value Manufacturing Catapult
Director of Innovation Ecosystem at Innovate UK (UK Research and Innovation)

Across two panels the Committee will first gain insights from the experience of CEOs and founders of science and technology start-up and spin-out companies in the UK – the people innovating and taking the risks to bring new technologies to market.   

The second panel, of research and technology agencies and “catapult” organisations, will describe the UK’s current efforts and support to translate research and innovation into commercial products.  

How easy is it for companies looking to commercialise scientific research in the UK to access the expertise and finance they need? 

Is Government getting the funding and support balance right to foster innovation and capitalise on the UK’s advanced scientific research?  

 

Location

Room 6, Palace of Westminster

How to attend